Application of Tongxinluo in preparing medicament for treating pulmonary hypertension
A technology of pulmonary hypertension and Tongxinluo, which is applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., to improve reconstruction, treat pulmonary hypertension, and reduce pulmonary vascular resistance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0011] 1. Materials and methods
[0012] 1.1 Establishment of Rat Pulmonary Hypertension Model
[0013] Male SPF grade SD rats, weighing 200-220g. One-time subcutaneous injection of monocrotaline (Monocrotaline, MCT, 40mg / kg), 3 weeks later, right heart catheterization was used randomly to measure pulmonary artery pressure and hemodynamic parameters to identify whether the model was successfully established.
[0014] 1.2 Experimental grouping and drug intervention
[0015] (1) Model group (MCT group): 10 rats were given normal saline by intragastric administration after the pulmonary hypertension model was successfully established for 3 consecutive weeks.
[0016] (2) Tongxinluo low-dose group (Tongxinluo 0.2g·kg·d group): 10 rats were given Tongxinluo by intragastric administration after the pulmonary hypertension model was successfully established for 3 consecutive weeks.
[0017] (3) Tongxinluo medium-dose group (Tongxinluo 0.4g·kg·d group): 10 rats were given Tongxinluo...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com